Table 3.
Name | Dose (mg/L) | No. of Subjects | Estimated Mean | Mortality (Days) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Days | Std. | 95% C.I. | 25% | 50% | 75% | 90% | 100% | |||
Control | 0 | 100 | 17.26 | 0.47 | 16.34–18.18 | 14 | 16 | 20 | 24 | 29 |
AFB1 | 2.05 | 100 | 4.85 | 0.19 | 4.48–5.22 | 3 | 5 | 6 | 7 | 9 |
DON | 65.67 | 100 | 5.19 | 0.35 | 4.50–5.88 | 2 | 4 | 8 | 11 | 12 |
FB1 | 23.56 | 100 | 5.66 | 0.26 | 5.15–6.17 | 3 | 6 | 7 | 9 | 12 |
T-2 | 0.14 | 100 | 3.83 | 0.19 | 3.46–4.20 | 3 | 4 | 5 | 6 | 10 |
ZEA | 7.58 | 100 | 4.79 | 0.22 | 4.36–5.22 | 3 | 5 | 6 | 7 | 10 |